AMN HEALTHCARE SERVICES INC (AMN) Stock Fundamental Analysis
NYSE:AMN • US0017441017
20.4 USD
-0.41 (-1.97%)
At close: Feb 24, 2026
20.3 USD
-0.1 (-0.49%)
After Hours: 2/24/2026, 8:08:36 PM
Overall AMN gets a fundamental rating of 3 out of 10. We evaluated AMN against 101 industry peers in the Health Care Providers & Services industry. AMN scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. AMN has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
- In the past year AMN was profitable.
- AMN had a positive operating cash flow in the past year.
- In multiple years AMN reported negative net income over the last 5 years.
- Of the past 5 years AMN 4 years had a positive operating cash flow.
1.2 Ratios
- AMN has a Return On Assets of -12.88%. This is in the lower half of the industry: AMN underperforms 77.23% of its industry peers.
- AMN has a worse Return On Equity (-42.76%) than 71.29% of its industry peers.
- The Return On Invested Capital of AMN (2.22%) is comparable to the rest of the industry.
- AMN had an Average Return On Invested Capital over the past 3 years of 6.19%. This is below the industry average of 8.93%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -12.88% | ||
| ROE | -42.76% | ||
| ROIC | 2.22% |
ROA(3y)-1.15%
ROA(5y)4.48%
ROE(3y)-3.45%
ROE(5y)12.07%
ROIC(3y)6.19%
ROIC(5y)12.47%
1.3 Margins
- AMN's Operating Margin of 1.65% is in line compared to the rest of the industry. AMN outperforms 45.54% of its industry peers.
- AMN's Operating Margin has declined in the last couple of years.
- AMN has a Gross Margin of 29.37%. This is comparable to the rest of the industry: AMN outperforms 58.42% of its industry peers.
- In the last couple of years the Gross Margin of AMN has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 1.65% | ||
| PM (TTM) | N/A | ||
| GM | 29.37% |
OM growth 3Y-53.83%
OM growth 5Y-32.3%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.69%
GM growth 5Y-3.04%
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), AMN is destroying value.
- Compared to 1 year ago, AMN has more shares outstanding
- The number of shares outstanding for AMN has been reduced compared to 5 years ago.
- AMN has a better debt/assets ratio than last year.
2.2 Solvency
- AMN has an Altman-Z score of 2.47. This is not the best score and indicates that AMN is in the grey zone with still only limited risk for bankruptcy at the moment.
- AMN has a Altman-Z score (2.47) which is comparable to the rest of the industry.
- AMN has a debt to FCF ratio of 3.80. This is a good value and a sign of high solvency as AMN would need 3.80 years to pay back of all of its debts.
- The Debt to FCF ratio of AMN (3.80) is better than 71.29% of its industry peers.
- A Debt/Equity ratio of 1.31 is on the high side and indicates that AMN has dependencies on debt financing.
- With a Debt to Equity ratio value of 1.31, AMN is not doing good in the industry: 65.35% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.31 | ||
| Debt/FCF | 3.8 | ||
| Altman-Z | 2.47 |
ROIC/WACC0.3
WACC7.4%
2.3 Liquidity
- AMN has a Current Ratio of 1.05. This is a normal value and indicates that AMN is financially healthy and should not expect problems in meeting its short term obligations.
- Looking at the Current ratio, with a value of 1.05, AMN is doing worse than 66.34% of the companies in the same industry.
- A Quick Ratio of 1.05 indicates that AMN should not have too much problems paying its short term obligations.
- AMN has a worse Quick ratio (1.05) than 60.40% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.05 | ||
| Quick Ratio | 1.05 |
3. Growth
3.1 Past
- The earnings per share for AMN have decreased strongly by -58.91% in the last year.
- Measured over the past years, AMN shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -16.94% on average per year.
- Looking at the last year, AMN shows a decrease in Revenue. The Revenue has decreased by -8.49% in the last year.
- Measured over the past years, AMN shows a small growth in Revenue. The Revenue has been growing by 2.67% on average per year.
EPS 1Y (TTM)-58.91%
EPS 3Y-51.4%
EPS 5Y-16.94%
EPS Q2Q%-70.67%
Revenue 1Y (TTM)-8.49%
Revenue growth 3Y-19.55%
Revenue growth 5Y2.67%
Sales Q2Q%1.84%
3.2 Future
- AMN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 52.37% yearly.
- The Revenue is expected to grow by 7.67% on average over the next years.
EPS Next Y-49.83%
EPS Next 2Y-9.69%
EPS Next 3Y78.98%
EPS Next 5Y52.37%
Revenue Next Year-5.63%
Revenue Next 2Y-0.9%
Revenue Next 3Y8.06%
Revenue Next 5Y7.67%
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- AMN is valuated correctly with a Price/Earnings ratio of 15.00.
- Compared to the rest of the industry, the Price/Earnings ratio of AMN indicates a rather cheap valuation: AMN is cheaper than 81.19% of the companies listed in the same industry.
- AMN's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.98.
- A Price/Forward Earnings ratio of 29.90 indicates a quite expensive valuation of AMN.
- AMN's Price/Forward Earnings is on the same level as the industry average.
- AMN is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 28.01, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15 | ||
| Fwd PE | 29.9 |
4.2 Price Multiples
- Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of AMN indicates a somewhat cheap valuation: AMN is cheaper than 79.21% of the companies listed in the same industry.
- AMN's Price/Free Cash Flow ratio is rather cheap when compared to the industry. AMN is cheaper than 98.02% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 3.52 | ||
| EV/EBITDA | 7.74 |
4.3 Compensation for Growth
- A more expensive valuation may be justified as AMN's earnings are expected to grow with 78.98% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-9.69%
EPS Next 3Y78.98%
5. Dividend
5.1 Amount
- No dividends for AMN!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
20.4
-0.41 (-1.97%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-19 2026-02-19/amc
Earnings (Next)05-06 2026-05-06/amc
Inst Owners109.44%
Inst Owner Change-2.04%
Ins Owners0.45%
Ins Owner Change9.04%
Market Cap783.56M
Revenue(TTM)2.73B
Net Income(TTM)-275.54M
Analysts69.23
Price Target21.27 (4.26%)
Short Float %5.11%
Short Ratio1.61
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)73.35%
Min EPS beat(2)53.64%
Max EPS beat(2)93.07%
EPS beat(4)4
Avg EPS beat(4)78.74%
Min EPS beat(4)52.24%
Max EPS beat(4)116.02%
EPS beat(8)8
Avg EPS beat(8)44.14%
EPS beat(12)12
Avg EPS beat(12)33.45%
EPS beat(16)16
Avg EPS beat(16)27.33%
Revenue beat(2)1
Avg Revenue beat(2)0.79%
Min Revenue beat(2)-0.06%
Max Revenue beat(2)1.64%
Revenue beat(4)3
Avg Revenue beat(4)2.05%
Min Revenue beat(4)-0.06%
Max Revenue beat(4)4.75%
Revenue beat(8)5
Avg Revenue beat(8)1.13%
Revenue beat(12)7
Avg Revenue beat(12)1.02%
Revenue beat(16)11
Avg Revenue beat(16)1.39%
PT rev (1m)2.1%
PT rev (3m)-0.34%
EPS NQ rev (1m)2.3%
EPS NQ rev (3m)2.3%
EPS NY rev (1m)2.26%
EPS NY rev (3m)23.61%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)4.59%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15 | ||
| Fwd PE | 29.9 | ||
| P/S | 0.29 | ||
| P/FCF | 3.52 | ||
| P/OCF | 2.94 | ||
| P/B | 1.22 | ||
| P/tB | N/A | ||
| EV/EBITDA | 7.74 |
EPS(TTM)1.36
EY6.67%
EPS(NY)0.68
Fwd EY3.34%
FCF(TTM)5.8
FCFY28.43%
OCF(TTM)6.94
OCFY34.04%
SpS70.73
BVpS16.78
TBVpS-10.76
PEG (NY)N/A
PEG (5Y)N/A
Graham Number22.66
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -12.88% | ||
| ROE | -42.76% | ||
| ROCE | 2.81% | ||
| ROIC | 2.22% | ||
| ROICexc | 2.3% | ||
| ROICexgc | 7.3% | ||
| OM | 1.65% | ||
| PM (TTM) | N/A | ||
| GM | 29.37% | ||
| FCFM | 8.2% |
ROA(3y)-1.15%
ROA(5y)4.48%
ROE(3y)-3.45%
ROE(5y)12.07%
ROIC(3y)6.19%
ROIC(5y)12.47%
ROICexc(3y)6.27%
ROICexc(5y)13.02%
ROICexgc(3y)21.12%
ROICexgc(5y)45.11%
ROCE(3y)7.84%
ROCE(5y)15.78%
ROICexgc growth 3Y-59.99%
ROICexgc growth 5Y-29.62%
ROICexc growth 3Y-59.19%
ROICexc growth 5Y-26.95%
OM growth 3Y-53.83%
OM growth 5Y-32.3%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.69%
GM growth 5Y-3.04%
F-Score4
Asset Turnover1.27
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.31 | ||
| Debt/FCF | 3.8 | ||
| Debt/EBITDA | 4.12 | ||
| Cap/Depr | 27.3% | ||
| Cap/Sales | 1.62% | ||
| Interest Coverage | 0.95 | ||
| Cash Conversion | 129.62% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.05 | ||
| Quick Ratio | 1.05 | ||
| Altman-Z | 2.47 |
F-Score4
WACC7.4%
ROIC/WACC0.3
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-58.91%
EPS 3Y-51.4%
EPS 5Y-16.94%
EPS Q2Q%-70.67%
EPS Next Y-49.83%
EPS Next 2Y-9.69%
EPS Next 3Y78.98%
EPS Next 5Y52.37%
Revenue 1Y (TTM)-8.49%
Revenue growth 3Y-19.55%
Revenue growth 5Y2.67%
Sales Q2Q%1.84%
Revenue Next Year-5.63%
Revenue Next 2Y-0.9%
Revenue Next 3Y8.06%
Revenue Next 5Y7.67%
EBIT growth 1Y-66.5%
EBIT growth 3Y-62.85%
EBIT growth 5Y-30.5%
EBIT Next Year219.97%
EBIT Next 3Y39.54%
EBIT Next 5YN/A
FCF growth 1Y102.15%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y29.17%
OCF growth 3YN/A
OCF growth 5YN/A
AMN HEALTHCARE SERVICES INC / AMN FAQ
What is the fundamental rating for AMN stock?
ChartMill assigns a fundamental rating of 3 / 10 to AMN.
Can you provide the valuation status for AMN HEALTHCARE SERVICES INC?
ChartMill assigns a valuation rating of 5 / 10 to AMN HEALTHCARE SERVICES INC (AMN). This can be considered as Fairly Valued.
How profitable is AMN HEALTHCARE SERVICES INC (AMN) stock?
AMN HEALTHCARE SERVICES INC (AMN) has a profitability rating of 2 / 10.
What is the earnings growth outlook for AMN HEALTHCARE SERVICES INC?
The Earnings per Share (EPS) of AMN HEALTHCARE SERVICES INC (AMN) is expected to decline by -49.83% in the next year.